Eliem Therapeutics jumps in Nasdaq debut

Climb Bio

10/08/2021 18:30

** Shares of biotech co Eliem Therapeutics  ELYM.O  jump 30%
in their Nasdaq debut 
    ** Shares open at $16.25; IPO was priced at $12.50
    ** Co sold 6.4 mln shares in an upsized IPO on Monday,
raising about $80 mln; it had earlier planned to sell 4.5 mln
shares priced between $17 and $19 per share
    ** ELYM is focused on development of therapies for chronic
pain, psychiatry, epilepsy and other disorders affecting the
peripheral and central nervous system 

 (Reporting by Sohini Podder in Bengaluru)
 ((sohini.podder@thomsonreuters.com))